For HIV-1–negative, at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1. See full Indication.
Resources
Access the resources below for additional details about APRETUDE, such as, the full Prescribing Information, including Instructions for Use, and downloadable resources such as dosing and drug interactions, getting started guide, and more.
Resources for Healthcare Professionals
Prescribing Information
See the full Prescribing Information, including Boxed Warning, for APRETUDE
Readiness Considerations Checklist
Review clinical considerations for appropriate patients when prescribing APRETUDE and readying your practice
Dosing and Admin Guide
Learn more about dosing and administration steps for APRETUDE
Getting Started Overview
Get detailed information on getting started with prescribed APRETUDE
Implementation FAQs
Answers to frequently asked questions about implementing APRETUDE into your practice
Instructions for Use
A helpful tool for complete preparation and injection instructions
Recommendations
CBTWCNT210025